Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 319

1.

[Neurobiology of endocannabinoids and central effects of tetrahydrocannabinol contained in indian hemp].

Costentin J.

Bull Acad Natl Med. 2014 Mar;198(3):527-38; discussion 538-9. Review. French.

PMID:
26427295
2.

[Cannabis in France, new insights].

Costentin J.

Bull Acad Natl Med. 2014 Mar;198(3):517-26. French.

PMID:
26427294
3.

[Not Available].

Costentin J, Goulli JP, Dubois G.

Bull Acad Natl Med. 2015 Jun;199(6):965-966. No abstract available.

PMID:
29901898
4.

Differential involvement of anxiety and novelty preference levels on oral ethanol consumption in rats.

Pelloux Y, Costentin J, Duterte-Boucher D.

Psychopharmacology (Berl). 2015 Aug;232(15):2711-21. doi: 10.1007/s00213-015-3910-5. Epub 2015 Mar 13.

PMID:
25761842
5.

[Controlled drug consumption rooms].

Allilaire JF, Costentin J, Goullé JP, Hamon M, Laqueille X, Lejoyeux M, Mouren MC, Olié JP, Nordmann R, Tillement JP.

Bull Acad Natl Med. 2013 Feb;197(2):503-5. French. No abstract available.

PMID:
24919375
6.

Dopa-decarboxylase gene polymorphisms affect the motor response to L-dopa in Parkinson's disease.

Devos D, Lejeune S, Cormier-Dequaire F, Tahiri K, Charbonnier-Beaupel F, Rouaix N, Duhamel A, Sablonnière B, Bonnet AM, Bonnet C, Zahr N, Costentin J, Vidailhet M, Corvol JC.

Parkinsonism Relat Disord. 2014 Feb;20(2):170-5. doi: 10.1016/j.parkreldis.2013.10.017. Epub 2013 Oct 24.

PMID:
24216088
7.

Acute and subchronic treatments with selective serotonin reuptake inhibitors increase Nociceptin/Orphanin FQ (NOP) receptor density in the rat dorsal raphe nucleus; interactions between nociceptin/NOP system and serotonin.

Le Maître E, Dourmap N, Vilpoux C, Leborgne R, Janin F, Bonnet JJ, Costentin J, Leroux-Nicollet I.

Brain Res. 2013 Jul 3;1520:51-60. doi: 10.1016/j.brainres.2013.05.005. Epub 2013 May 10.

PMID:
23669068
8.

[Treatment of insomnia. Pharmacological approaches and their limitations].

Costentin J.

Bull Acad Natl Med. 2011 Oct;195(7):1583-94; discussion 1594-5. French.

PMID:
22812162
9.

Rational design of a low molecular weight, stable, potent, and long-lasting GPR103 aza-β3-pseudopeptide agonist.

Neveu C, Lefranc B, Tasseau O, Do-Rego JC, Bourmaud A, Chan P, Bauchat P, Le Marec O, Chuquet J, Guilhaudis L, Boutin JA, Ségalas-Milazzo I, Costentin J, Vaudry H, Baudy-Floc'h M, Vaudry D, Leprince J.

J Med Chem. 2012 Sep 13;55(17):7516-24. doi: 10.1021/jm300507d. Epub 2012 Aug 17.

PMID:
22800498
10.

Influence of corticostriatal δ-opioid receptors on abnormal involuntary movements induced by L-DOPA in hemiparkinsonian rats.

Billet F, Costentin J, Dourmap N.

Exp Neurol. 2012 Aug;236(2):339-50. doi: 10.1016/j.expneurol.2012.04.017. Epub 2012 May 1.

PMID:
22575599
11.

Uliginosin B, a phloroglucinol derivative from Hypericum polyanthemum: a promising new molecular pattern for the development of antidepressant drugs.

Stein AC, Viana AF, Müller LG, Nunes JM, Stolz ED, Do Rego JC, Costentin J, von Poser GL, Rates SM.

Behav Brain Res. 2012 Mar 1;228(1):66-73. doi: 10.1016/j.bbr.2011.11.031. Epub 2011 Dec 2.

PMID:
22155486
12.

Effect of potent endomorphin degradation blockers on analgesic and antidepressant-like responses in mice.

Cravezic A, Fichna J, Gach K, Wyrebska A, Perlikowska R, Costentin J, Bonnet JJ, Janecka A, do Rego JC.

Neuropharmacology. 2011 Dec;61(8):1229-38. doi: 10.1016/j.neuropharm.2011.07.021. Epub 2011 Jul 22.

PMID:
21803061
13.

Structure-activity relationships of a series of analogues of the RFamide-related peptide 26RFa.

Le Marec O, Neveu C, Lefranc B, Dubessy C, Boutin JA, Do-Régo JC, Costentin J, Tonon MC, Tena-Sempere M, Vaudry H, Leprince J.

J Med Chem. 2011 Jul 14;54(13):4806-14. doi: 10.1021/jm200418c. Epub 2011 Jun 9.

PMID:
21623631
14.

The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: a randomized crossover clinical trial.

Corvol JC, Bonnet C, Charbonnier-Beaupel F, Bonnet AM, Fiévet MH, Bellanger A, Roze E, Meliksetyan G, Ben Djebara M, Hartmann A, Lacomblez L, Vrignaud C, Zahr N, Agid Y, Costentin J, Hulot JS, Vidailhet M.

Ann Neurol. 2011 Jan;69(1):111-8. doi: 10.1002/ana.22155.

PMID:
21280081
15.

[Cannabis: a false medication, a true drug].

Costentin J; Commission VI (Addictions).

Bull Acad Natl Med. 2010 Feb;194(2):445-6. French. No abstract available.

PMID:
21166132
16.

Erythrocytes catechol-o-methyl transferase activity is up-regulated after a 3-month treatment by entacapone in parkinsonian patients.

Maltête D, Cottard AM, Mihout B, Costentin J.

Clin Neuropharmacol. 2011 Jan-Feb;34(1):21-3. doi: 10.1097/WNF.0b013e318205dff7.

PMID:
21164341
17.

Increased erythrocyte catechol-O-methyltransferase activity in elderly: relationship to clinical peculiarities in Parkinson's disease?

Maltête D, Edouard T, Mihout B, Costentin J.

Int J Geriatr Psychiatry. 2010 Mar;25(3):323-4. doi: 10.1002/gps.2311. No abstract available.

PMID:
20148410
18.

Structural and pharmacological characteristics of chimeric peptides derived from peptide E and beta-endorphin reveal the crucial role of the C-terminal YGGFL and YKKGE motifs in their analgesic properties.

Condamine E, Courchay K, Rego JC, Leprince J, Mayer C, Davoust D, Costentin J, Vaudry H.

Peptides. 2010 May;31(5):962-72. doi: 10.1016/j.peptides.2010.01.012. Epub 2010 Feb 4.

PMID:
20138196
19.

Synthesis, radiosynthesis and biological evaluation of 1,4-dihydroquinoline derivatives as new carriers for specific brain delivery.

Foucout L, Gourand F, Dhilly M, Bohn P, Dupas G, Costentin J, Abbas A, Marsais F, Barré L, Levacher V.

Org Biomol Chem. 2009 Sep 21;7(18):3666-73. doi: 10.1039/b909650g. Epub 2009 Jul 10.

PMID:
19707670
20.

[A new approach to antischizophrenic therapeutics: D2 dopamine receptor partial agonists].

Costentin J.

Ann Pharm Fr. 2009 Sep;67(5):310-9. doi: 10.1016/j.pharma.2009.05.004. Epub 2009 Jul 18. Review. French.

PMID:
19695367
21.

[Expert opinion on APAP (prolonged action atypical antipsychotic agents). Foreword].

Guelfi JD, Costentin J, Terra JL.

Encephale. 2009 Jan;Suppl 3:S85-6. doi: 10.1016/S0013-7006(09)75541-1. French. No abstract available.

PMID:
19268183
22.

[Expert opinion on APAP (prolonged action atypical antipsychotic agents). Position of the pharmacologist. From neuroleptics to non-neuroleptic antipsychotics].

Costentin J.

Encephale. 2009 Jan;Suppl 3:S119-22. doi: 10.1016/S0013-7006(09)75548-4. French. No abstract available.

PMID:
19268181
23.

Rational design of central selective acetylcholinesterase inhibitors by means of a "bio-oxidisable prodrug" strategy.

Bohn P, Le Fur N, Hagues G, Costentin J, Torquet N, Papamicaël C, Marsais F, Levacher V.

Org Biomol Chem. 2009 Jun 21;7(12):2612-8. doi: 10.1039/b903041g. Epub 2009 May 18.

PMID:
19503937
24.

Adenosine A2A receptor deficient mice are partially resistant to limbic seizures.

El Yacoubi M, Ledent C, Parmentier M, Costentin J, Vaugeois JM.

Naunyn Schmiedebergs Arch Pharmacol. 2009 Sep;380(3):223-32. doi: 10.1007/s00210-009-0426-8. Epub 2009 Jun 2.

PMID:
19488739
25.

[A new pharmacological strategy for schizophrenia: the partial agonists of D2 dopaminergic receptors. The principle characteristics of aripiprazole].

Costentin J.

Encephale. 2009 Feb;35(1):66-72. doi: 10.1016/j.encep.2008.12.001. Epub 2009 Feb 5. Review. French.

PMID:
19250996
26.

[Neuropsychopharmacology of delta-9-tetrahydrocannabinol].

Costentin J.

Ann Pharm Fr. 2008 Aug;66(4):219-31. doi: 10.1016/j.pharma.2008.07.003. Epub 2008 Sep 4. Review. French.

PMID:
18847570
27.

[Illicit drugs, medications and traffic accidents].

Goullé JP, Verstraete A, Boulu R, Costentin J, Foucher JP, Raes E, Tillement JP.

Ann Pharm Fr. 2008 Aug;66(4):196-205. doi: 10.1016/j.pharma.2008.06.002. Epub 2008 Aug 23. Review. French.

PMID:
18847565
28.

Regulation of feeding and anxiety by alpha-MSH reactive autoantibodies.

Sinno MH, Do Rego JC, Coëffier M, Bole-Feysot C, Ducrotté P, Gilbert D, Tron F, Costentin J, Hökfelt T, Déchelotte P, Fetissov SO.

Psychoneuroendocrinology. 2009 Jan;34(1):140-9. doi: 10.1016/j.psyneuen.2008.08.021. Epub 2008 Oct 8.

PMID:
18842346
29.

Anxiety increases the place conditioning induced by cocaine in rats.

Pelloux Y, Costentin J, Duterte-Boucher D.

Behav Brain Res. 2009 Feb 11;197(2):311-6. doi: 10.1016/j.bbr.2008.08.029. Epub 2008 Aug 29.

PMID:
18793676
30.

[Clinical potentialities and perspectives for the use of aripiprazole in other disorders than its classical indications. A critical analysis of the recent literature].

Crocq MA, Camus V, Millet B, Gliskman J, Azorin JM, Krebs MO, Limosin F, Costentin J, Daléry J.

Encephale. 2008 Apr;34(2):187-93. doi: 10.1016/j.encep.2007.12.004. Epub 2008 Mar 5. Review. French.

PMID:
18597728
31.

Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system.

Mounien L, Do Rego JC, Bizet P, Boutelet I, Gourcerol G, Fournier A, Brabet P, Costentin J, Vaudry H, Jégou S.

Neuropsychopharmacology. 2009 Jan;34(2):424-35. doi: 10.1038/npp.2008.73. Epub 2008 Jun 4.

32.

[Present data and treatment schedule of aripiprazole in the treatment of schizophrenia].

Limosin F, Azorin JM, Krebs MO, Millet B, Glikman J, Camus V, Crocq MA, Costentin J, Daléry J.

Encephale. 2008 Jan;34(1):82-92. doi: 10.1016/j.encep.2007.12.003. Epub 2008 Feb 20. Review. French.

PMID:
18514155
33.

Evidence for the involvement of the adenosine A(2A) receptor in the lowered susceptibility to pentylenetetrazol-induced seizures produced in mice by long-term treatment with caffeine.

El Yacoubi M, Ledent C, Parmentier M, Costentin J, Vaugeois JM.

Neuropharmacology. 2008 Jul;55(1):35-40. doi: 10.1016/j.neuropharm.2008.04.007. Epub 2008 Apr 18.

PMID:
18486156
34.

Locomotor effects of morphine or alcohol in mice after a repeated treatment with the cannabinoid agonist HU 210.

Hagues G, Costentin J, Duterte-Boucher D.

Eur J Pharmacol. 2008 May 31;586(1-3):197-204. doi: 10.1016/j.ejphar.2008.02.062. Epub 2008 Feb 29.

PMID:
18400220
35.

[Seeing a new classification of active medications in psychoses].

Costentin J.

Encephale. 2007 Oct;33(5):721-2. French. No abstract available.

PMID:
18357841
36.

Synthesis and biological effects of c(Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu) (JMV2012), a new analogue of neurotensin that crosses the blood-brain barrier.

Bredeloux P, Cavelier F, Dubuc I, Vivet B, Costentin J, Martinez J.

J Med Chem. 2008 Mar 27;51(6):1610-6. doi: 10.1021/jm700925k. Epub 2008 Mar 6.

PMID:
18321036
37.

Effects of acute or 3-day treatments of Hypericum caprifoliatum Cham. & Schltdt. (Guttiferae) extract or of two established antidepressants on basal and stress-induced increase in serum and brain corticosterone levels.

Viana A, Rates S, Naudin B, Janin F, Costentin J, do Rego JC.

J Psychopharmacol. 2008 Aug;22(6):681-90. doi: 10.1177/0269881107082898. Epub 2008 Feb 28.

PMID:
18308787
38.

Behavioral actions of urotensin-II.

do Rego JC, Leprince J, Scalbert E, Vaudry H, Costentin J.

Peptides. 2008 May;29(5):838-44. doi: 10.1016/j.peptides.2007.12.016. Epub 2008 Jan 17. Review.

PMID:
18294732
39.

[Dmt1, d-1-Nal3]morphiceptin, a novel opioid peptide analog with high analgesic activity.

Fichna J, do-Rego JC, Chung NN, Costentin J, Schiller PW, Janecka A.

Peptides. 2008 Apr;29(4):633-8. doi: 10.1016/j.peptides.2007.12.005. Epub 2007 Dec 23.

PMID:
18234394
40.

Novel highly potent mu-opioid receptor antagonist based on endomorphin-2 structure.

Fichna J, do-Rego JC, Janecki T, Staniszewska R, Poels J, Broeck JV, Costentin J, Schiller PW, Janecka A.

Bioorg Med Chem Lett. 2008 Feb 15;18(4):1350-3. doi: 10.1016/j.bmcl.2008.01.009. Epub 2008 Jan 8.

PMID:
18207400
41.

The reduction in electric footshocks perception interferes with the amnesic effect of scopolamine.

Torquet N, Hagues G, Costentin J.

Behav Brain Res. 2008 Mar 17;188(1):238-40. Epub 2007 Nov 19.

PMID:
18160109
42.

Influence of glial cells in the dopamine releasing effect resulting from the stimulation of striatal delta-opioid receptors.

Billet F, Costentin J, Dourmap N.

Neuroscience. 2007 Nov 30;150(1):131-43. Epub 2007 Sep 19.

PMID:
17942234
43.

Antidepressant-like effect of hyperfoliatin, a polyisoprenylated phloroglucinol derivative from Hypericum perfoliatum (Clusiaceae) is associated with an inhibition of neuronal monoamines uptake.

do Rego JC, Benkiki N, Chosson E, Kabouche Z, Seguin E, Costentin J.

Eur J Pharmacol. 2007 Aug 27;569(3):197-203. Epub 2007 May 13.

PMID:
17574234
44.

[Good use of the word "drogue" in French language].

Costentin J.

Therapie. 2006 Nov-Dec;61(6):553-4. French. No abstract available.

PMID:
17348617
45.

The endomorphin system and its evolving neurophysiological role.

Fichna J, Janecka A, Costentin J, Do Rego JC.

Pharmacol Rev. 2007 Mar;59(1):88-123. Review.

PMID:
17329549
46.

Comparisons between bupropion and dexamphetamine in a range of in vivo tests exploring dopaminergic transmission.

Bredeloux P, Dubuc I, Costentin J.

Br J Pharmacol. 2007 Mar;150(6):711-9. Epub 2007 Feb 12.

47.

Synthesis and characterization of potent and selective mu-opioid receptor antagonists, [Dmt(1), D-2-Nal(4)]endomorphin-1 (Antanal-1) and [Dmt(1), D-2-Nal(4)]endomorphin-2 (Antanal-2).

Fichna J, do-Rego JC, Chung NN, Lemieux C, Schiller PW, Poels J, Broeck JV, Costentin J, Janecka A.

J Med Chem. 2007 Feb 8;50(3):512-20.

PMID:
17266203
48.

Modulation of morphine and alcohol motor stimulant effects by cannabinoid receptors ligands.

Hagues G, Costentin J, Duterte-Boucher D.

Behav Brain Res. 2007 Mar 28;178(2):274-82. Epub 2007 Jan 23.

PMID:
17254644
49.

Pharmacological characterization of the receptor mediating the anorexigenic action of the octadecaneuropeptide: evidence for an endozepinergic tone regulating food intake.

do Rego JC, Orta MH, Leprince J, Tonon MC, Vaudry H, Costentin J.

Neuropsychopharmacology. 2007 Jul;32(7):1641-8. Epub 2006 Dec 6.

50.

Hypericum caprifoliatum (Guttiferae) Cham. & Schltdl.: a species native to South Brazil with antidepressant-like activity.

Viana AF, do Rego JC, Munari L, Dourmap N, Heckler AP, Costa TD, von Poser GL, Costentin J, Rates SM.

Fundam Clin Pharmacol. 2006 Dec;20(6):507-14. Review.

PMID:
17109644

Supplemental Content

Loading ...
Support Center